Version 1
: Received: 20 September 2024 / Approved: 23 September 2024 / Online: 23 September 2024 (13:13:06 CEST)
How to cite:
Hosu, M. C.; Faye, L. M.; Apalata, A. T. Predicting Treatment Outcomes in Patients with Drug-resistant Tuberculosis and HIV Co-infection Using a Supervised Machine Learning Algorithm. Preprints2024, 2024091747. https://doi.org/10.20944/preprints202409.1747.v1
Hosu, M. C.; Faye, L. M.; Apalata, A. T. Predicting Treatment Outcomes in Patients with Drug-resistant Tuberculosis and HIV Co-infection Using a Supervised Machine Learning Algorithm. Preprints 2024, 2024091747. https://doi.org/10.20944/preprints202409.1747.v1
Hosu, M. C.; Faye, L. M.; Apalata, A. T. Predicting Treatment Outcomes in Patients with Drug-resistant Tuberculosis and HIV Co-infection Using a Supervised Machine Learning Algorithm. Preprints2024, 2024091747. https://doi.org/10.20944/preprints202409.1747.v1
APA Style
Hosu, M. C., Faye, L. M., & Apalata, A. T. (2024). Predicting Treatment Outcomes in Patients with Drug-resistant Tuberculosis and HIV Co-infection Using a Supervised Machine Learning Algorithm. Preprints. https://doi.org/10.20944/preprints202409.1747.v1
Chicago/Turabian Style
Hosu, M. C., Lindiwe Modest Faye and and Teke Apalata. 2024 "Predicting Treatment Outcomes in Patients with Drug-resistant Tuberculosis and HIV Co-infection Using a Supervised Machine Learning Algorithm" Preprints. https://doi.org/10.20944/preprints202409.1747.v1
Abstract
Drug-resistant tuberculosis (DR-TB) and HIV-coinfection present a conundrum to public health globally, and the achievement of the global END TB strategy in 2035. A descriptive, retrospective review of medical records of patients diagnosed with DR-TB who received treatment was conducted. Student’s t-test was performed to assess differences between two means and ANOVA between groups. Either the Chi-square test with and without trend or Fischer’s exact test was used to test the degree of association of categorical variables. Logistic regression was used to determine predictors of DR-TB treatment outcomes. Also, a decision tree classifier, which is a supervised machine learning algorithm was used. Python version 3.8. and R version 4.1.1 software were used for data analysis. A p-value of 0.05 with a 95% confidence interval (CI) was used to determine statistical significance. A total of 456 DR-TB patients were included in the study with more male patients (n = 256, 56.1%) than female patients (n = 200, 43.9%). The overall treatment success rate was 61.4%. There was a significant decrease in the % of patients cured during the Covid-19 pandemic compared to the pre-pandemic period. Our findings showed that machine learning can be used to predict TB patients' treatment outcomes.
Public Health and Healthcare, Public Health and Health Services
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
